# Copeptin as a Diagnostic Marker in the Management of Neurosurgical Patients With Disturbance of Water Homeostasis

> **NCT01465672** · — · COMPLETED · sponsor: **University Hospital, Basel, Switzerland** · enrollment: 125 (actual)

## Conditions studied

- Pituitary Adenoma

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT01465672
- **Lead sponsor:** University Hospital, Basel, Switzerland
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2011-10
- **Primary completion:** 2013-12
- **Final completion:** 2013-12
- **Target enrollment:** 125 (ACTUAL)
- **Last updated:** 2014-05-20

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01465672

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01465672, "Copeptin as a Diagnostic Marker in the Management of Neurosurgical Patients With Disturbance of Water Homeostasis". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT01465672. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*